Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AH-8 Cream for Blepharospasm
NCT01750346Phase 2Terminated
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Nov 2012
- Primary completion
- May 2015
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of acetyl hexapeptide-8 in benign essential blepharospasm (BEB), sponsored by National Institute of Neurological Disorders and Stroke. Started Nov 2012; status: terminated.
02
Drugs
acetyl hexapeptide-8
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT01750346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750346.